Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer

OBJECTIVE: To compare effects and adverse events of anti-programmed cell death protein 1 (anti-PD-1) antibody combined with chemoradiotherapy (CRT) and CRT alone as the initial treatment in locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: We retrospectively reviewed locally advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ji, Yao, Nan, Lu, Jiaying, Qu, Wanxi, Cui, Li, Yuan, Shiwang, Li, Na, Tong, Shaodong, Qin, Zhaohui, Yao, Yuanhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947779/
https://www.ncbi.nlm.nih.gov/pubmed/36845696
http://dx.doi.org/10.3389/fonc.2023.1005856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947779/
https://www.ncbi.nlm.nih.gov/pubmed/36845696
http://dx.doi.org/10.3389/fonc.2023.1005856

Ejemplares similares